Cynapsus Therapeutics Inc. — Form D

Cynapsus Therapeutics Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2015-04-14. The offering totals $16.8M, of which $16.8M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Anthony GiovinazzoDirectorMississauga, A6
Tomer GoldDirectorToronto, A6
Ronald HoskingDirectorToronto, A6
Tamar D HowsonDirectorToronto, A6
Margaret Nan HutchinsonDirectorToronto, A6
Perry Nan MolinoffDirectorToronto, A6
Ilan Nan OrenDirectorToronto, A6
Rochelle D StenzlerDirectorToronto, A6
Thierry D BilbaultExecutive OfficerToronto, A6
Anthony GiovinazzoExecutive OfficerMississauga, A6
Andrew WilliamsExecutive OfficerHuntington Beach, CA
Ilan OrenDirectorMorrisville, NC
Nathan BrysonExecutive OfficerMorristown, NJ
DAVID HILLDirectorCharlotte, NC
Julia LevyDirectorAuburn, WA
Perry MolinoffDirectorDALLAS, TX
Nan HutchinsonDirectorToronto, A6
Rochelle D C StenzlerDirectorToronto, A6
Alan D C RyleyDirectorToronto, A6
Alan D C TorrieDirectorToronto, A6
Alan TorrieDirectorTORONTO, A6
Alan RyleyDirectorTORONTO, A6
Rochelle StenzlerDirectorTORONTO, A6

Other filings by this issuer (9)

FiledFormOfferingSold
2014-04-21D$42.9M$14.5M
2013-03-27D/A$13.0M$4.1M
2013-03-20D$2.4M
2013-03-15D$11.2M$3.9M
2012-03-28D/A$940K$940K
2012-01-09D/A$762K$762K
2011-12-28D/A$555K$555K
2011-11-18D/A$389K$389K
2011-10-13D$222K$222K

More